Concentra Group Holdings Parent, Inc. <CON.N>: Wells Fargo raises target price to $40 from $28
CON•Related News
Xtant Medical Q2 revenue falls on asset sales and lost license revenue
XTNT•
Revolution Medicines, Inc. <RVMD.O>: Truist Securities raises target price to $231 from $210
RVMD•
C4 Therapeutics Q2 revenue beats estimates, helped by Roche collaboration
CCCC•
Hinge Health, Inc. <HNGE.N>: Truist Securities Raises Target Price to $112 From $85
HNGE•
Hims & Hers Health, Inc.: TD Cowen Raises Target Price to $30 From $25
HIMS•